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The expression of pluripotency-associated proteins was conﬁrmed in
the iPS cell line generated from parental hBM MSC (MSC-iPSC (74))
(Fig. 1A). The expression of pluripotency-associated genes was compar-
atively conﬁrmed in MSC-iPSC (74) and hESC H1 using real time PCR
(Fig. 1B). In addition, microarray-based transcriptome proﬁling revealed
a high similarity between MSC-iPSC (74), hESC H1 and hESC H9 com-
pared to the parental hBM MSC (Fig. 1C and D). The somatic origin of
MSC-iPSC 74 and the absence of cross-contamination with embryonic
stem cell lines H1 and H9 were conﬁrmed by DNA ﬁngerprinting
(Fig. 1E). Karyotype analysis revealed a normal female karyotype
(Fig. 1F). In addition, pluripotency in MSC-iPSC (74) was conﬁrmed
in vitro using embryoid body based differentiation and. in vivo using
the teratoma assay (Fig. 2A and B).
3. Materials and methods
3.1. Ethics statement
Mesenchymal stromal cells, used for generation of the induced
pluripotent stem cell line, were isolated from the bone marrow of a
74-year-old female donor after written informed consent of the patient.
The corresponding protocol was approved by the research ethics board
of the Charite-Universitätsmedizin, Berlin (IRB approval EA2/126/07).
3.2. Cell culture
Parental hBM MSC were isolated from human bone marrow by
density separation using Histopaque®-1077 (Sigma-Aldrich) and(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Characterization of the iPS line. A) Conﬁrmation of pluripotency marker expression and the absence of the differentiation marker SSEA1 in MSC-iPSC (74). Immunoﬂuorescence
staining, red/green: detected marker; blue: DAPI to visualize nuclei. B) Conﬁrmation of the mRNA expression of pluripotency-associated genes in MSC-iPSC (74) and hESC H1, which
served as the control. The bars represent the Log2 of the mean value of the detected relative expression inMSC-iPSC (74) or hESC H1 over the detected relative expression in the parental
hBM-MSC. The error bars represent the standard deviation of three technical replicates. C) Clustering dendrogram generated with the software GenomeStudio (Illumina) based on the
Pearson correlation between the transcriptomes of parental hBM MSC, MSC-iPSC (74), hESC H1 and hESC H9. The mRNA expression values were detected using an Illumina Bead Chip
microarray. D) Values of the Pearson correlation co-efﬁcient between the transcriptomes of the same samples compared in the clustering dendrogram. The correlation values were cal-
culated using the software GenomeStudio (Illumina). E) Conﬁrmation of the somatic origin of MSC-iPSC (74) by DNA ﬁngerprinting using microsatellite-speciﬁc primers in a PCR with
genomic DNA of 1: MSC-iPSC (74), 2: parental hBM MSC, 3: hESC H1 and 4: hESC H9. F) Karyotyping analysis of MSC-iPSC (74). The analysis revealed a normal female karyotype.
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Dulbecco's modiﬁed Eagle's medium (DMEM; Life Technologies) sup-
plemented with 10% fetal calf serum (FCS; Biochrom), GlutaMAX™,
and 100 U/mL penicillin + 100 μg/mL streptomycin (all from Life Tech-
nologies) were used. IsolatedMSCwere routinely characterized accord-
ing theminimal criteria of the International Society for Cellular Therapy
(Dominici et al., 2006). In this regard, parental hBM MSC were positive(N95%) for CD73, CD105, and CD90, and negative (b2%) of CD14, CD19,
CD34, CD45, CD79α, and human leukocyte antigen-DR (HLA-DR). The
capacity of parental hBM MSC to differentiate into osteogenic,
adipogenic, and chondrogenic lineage was conﬁrmed by addition of ap-
propriate media as previously described (Glaeser et al., 2010).
Human embryonic stem cell (hESC) lines H1 and H9 (WiCell
(#WA01 and #WA09, respectively)) as well as the generated MSC-
Fig. 2. Conﬁrmation of ability to give rise to lineages of all three germ layers. A) Embryoid body-based in vitro test of pluripotency. MSC-iPSC (74) gave rise to cell lineages expressing
endodermal markers (SOX17) and α Fetoprotein (AFP), mesodermal markers Brachyury (T) and Smooth-Muscle-Actin (SMA) and ectodermal markers NESTIN and β-TubulinIII
(TUJ1). Detection by immunoﬂuorescence staining. red/green: detected marker; blue: DAPI to visualize nuclei. B) Pluripotency conﬁrmation by teratoma assay. MSC-iPSC (74) gave
rise to structures representative of the three germ layers. Expt 1: endoderm: tubular gland-like structure; mesoderm: bone; ectoderm: mucous gland. Expt 2: endoderm: gut-like epithe-
lium; mesoderm: bone; ectoderm: neuroepithelial structure. Hematoxylin and eosin staining of the teratoma tissue.
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KO-DMEMwith 20% knockout serum replacement, L-glutamine, nones-
sential amino acids, sodium pyruvate, penicillin/streptomycin, 0.1 mM
β-mercaptoethanol (all from Life Technologies). Basic ﬁbroblast growth
factor (bFGF) (Preprotech) was added with a ﬁnal concentration of
8 ng/mL. The cultures were passaged with a split ratio of 1:3 using a
syringe needle, pipette and binocular microscope. The pluripotent cells
were cultured onmitomycin-C-inactivatedmouse embryonic ﬁbroblasts
(MEFs) seeded on cell culture dishes coated with Matrigel (Beckton
Dickinson). All cultures were carried out in a humidiﬁed atmosphere at
37 °C as well as 5% O2 and 5% CO2.Table 1
Primer sequences used for DNA ﬁngerprinting and real time PCR.
Gene Forward primer sequence (5′-3′) Reverse primer sequence (5′-3´)
D7S796 TTTTGGTATTGGCCATCCTA GAAAGGAACAGAGAGACAGGG
D10S1214 ATTGCCCCAAAACTTTTTTG TTGAAGACCAGTCTGGGAAG
DNMT3B GCTCACAGGGCCCGATACTT GCAGTCCTGCAGCTCGAGTTTA
DPPA4 TGGTGTCAGGTGGTGTGTGG CCAGGCTTGACCAGCATGAA
FGF4 CCCTTCTTCACCGATGAGTGC CATTCTTGCTCAGGGCGATG
GDF3 TTGGCACAAGTGGATCATTGC TTGGCACAAGTGGATCATTGC
LEFTY1
AATGTGTCATTGTTTACTTGTCCT
GTC CAGGTCTTAGGTCCAGAGTGGTG
NANOG CCTGTGATTTGTGGGCCTG GACAGTCTCCGTGTGAGGCAT
OCT4 GTGGAGGAAGCTGACAACAA ATTCTCCAGGTTGCCTCTCA
SOX2 GTATCAGGAGTTGTCAAGGCAGAG
TCCTAGTCTTAAAGAGGCAGCA
AAC
TERT ACGGCGACATGGAGAACAAG
GAGGTGTCACCAACAAGAAATC
ATC
LIN28 GCACCAGAGTAAGCTGCACA ATGGATTCCAGACCCTTGGC
LEFTY2 CTCCCGCGGAAAGAGGTTC CAGCGCGGCCTCCGA
TDGF1 AGGGAACAATGACAGAGTGTGA CCCGGCAACTAATCCCAGTT3.3. Derivation of iPSCs
Parental hBMMSCwere seeded at a density of 2 × 105 cell perwell of
a six well plate for transduction with retroviruses expressing OCT4,
SOX2, KLF4 and c-MYC. Viral particles were generated in 293T cells
using a conventional CaCl2 transfection protocol. After transduction,
parental hBM MSC were split 1:3 onto Matrigel-coated cell culture
dishes on which inactivated MEFs were seeded as a feeder layer. The
transduced cells were further cultured for seven days in pluripotent
stem cell medium supplemented with 8 ng/mL bFGF. After day seven,
the cells were further cultured in a medium pre-conditioned with
inactivated MEF and supplemented with 0.5 μM of the MEK inhibitor
PD325901 (Stemgent, 04–0006), 2 μM of the TGFβ receptor inhibitor
SB431542 (Sigma, S4317) and 10 μM of the p53 inhibitor Piﬁthrin α
(Stemgent, 04–0038) (Hong et al., 2009; Lin et al., 2009) and with
daily medium changes. Colonies with hESC-looking morphology were
mechanically detached and transferred to a new Matrigel and feedercell coated culture dish for expansion and characterization as previously
described. (Hossini et al., 2015; Takahashi et al., 2007).3.4. DNA ﬁngerprinting analysis
To conﬁrm the somatic origin of MSC-iPSC (74) and rule out cross
contamination with hESCs, 50 ng of genomic DNA was ampliﬁed by
PCR 94 °C for 1 min, 55 °C for 1 min, 72 °C for 1 min, for 40 cycles, in a
Dyad thermal cycler (BioRad) as previously described (Prigione et al.,
2010). PCR products were resolved in 3% agarose gels to visualize
568 M. Megges et al. / Stem Cell Research 15 (2015) 565–568amplicon size patterns for each primer set: D7S796, D10S1214. The
primer sequences are listed in Table 1.
3.5. Quantitative real-time polymerase chain reaction
Expression analysis of pluripotency marker genes was carried out
using SYBR® Green PCR Master Mix (Life Technologies). The PCR was
performed with an ABI PRISM® 7000 Sequence Detection System (Life
Technologies). The software ABI PRISM SDS was used for data analysis.
Primer sequences are listed in Table 1. The datawere analyzed according
to the ΔΔCt method. The Log2 of relative expression measured in MSC-
iPSC (74) or hESC H1 over the relative expression measured in parental
hBM MSC with three technical replicates was calculated. The three
samples were pooled before reverse transcription of the RNA was
carried out.
3.6. Embryoid body based in-vitro test of pluripotency
MSC-iPSC (74) was split and seeded onto a 60 mm ultra low attach-
ment culture dish (Corning) and cultured in DMEM supplemented with
10% FCS, nonessential amino acids, L-glutamine, penicillin/streptomycin
and sodium pyruvate (all from Life Technologies) without additional
bFGF to generate embryoid bodies (EBs). After 10 days EBs were seeded
onto gelatine-coated culture dishes and grown another 10 days in
the same medium. Subsequently, the cells were ﬁxed with 4% parafor-
maldehyde and germ layer speciﬁc markers were visualized by
immunoﬂuorescence-based staining.
3.7. Immunoﬂuorescence-based analyses of pluripotency associated
proteins
To detect pluripotency-speciﬁc or germ layer-speciﬁc marker
expression,MSC-iPSCs (74)were ﬁxed using phosphate-buffered saline
(PBS) with 4% paraformaldehyde (Science) for 20min at room temper-
ature. The pluripotency markers OCT4, SOX2, KLF4, c-MYC, SSEA1,
SSEA4, TRA-1-60, TRA-1-81, and NANOG and the germ layer speciﬁc
markers α Fetoprotein (AFP) Smooth-Muscle-Actin (SMA), SOX17,
PAX6, NESTIN, β-TubulinIII (TUJ1) and Brachyury (T) were visualized
by immunoﬂuorescence labeling as previously described (Hossini
et al., 2015).
3.8. Conﬁrmation of pluripotency in vivo
To test the pluripotency of MSC-iPSC (74) in vivo, teratoma assays
were carried out by EPO-Berlin GmbH, Berlin-Buch, Germany. Undiffer-
entiated cells were detached by trypsinization, washed with PBS and
subsequently injected into NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice,which are known as NOD scid gamma (NSG) mice. The tumor was
harvested and analyzed for the presence of structures of endodermal,
ectodermal and mesodermal origin. The analysis was carried out at
the Institute for Animal Pathology, Berlin, Germany.
3.9. Microarray based gene expression analysis
Total RNA was isolated using a combined DNA, RNA, and Protein
extraction Kit (Roboklon, Berlin Germany). The RNA quality was ana-
lyzed using a Nanodrop spectrophotometer (Nanodrop). 500 ng of
total RNAwas used to produce biotin-labeled cRNAwith a linear ampli-
ﬁcation kit (Ambion). The Illumina BeadStation 500 platform (Illumina)
was used to further process the samples following the manufacturer's
instruction for hybridization and Cy3-streptavidin staining. cRNA
samples were hybridized onto HumanHT-8 v3.0 Gene Expression
BeadChips. The clustering dendrogram comparing the expression data
and the correlation values were calculated using the Gene Expression
Module of the software GenomeStudio (Illumina).
3.10. Karyotype analysis
GTG banding analysis was performed at Human Genetic Centre,
Berlin, Germany. 33 metaphases of MSC-iPSC (74) were analyzed.
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